SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-058866
Filing Date
2024-05-08
Accepted
2024-05-08 17:16:31
Documents
16
Period of Report
2024-03-13
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2413822d1_8ka.htm   iXBRL 8-K/A 31036
2 EXHIBIT 23.1 tm2413822d1_ex23-1.htm EX-23.1 2365
3 EXHIBIT 99.1 tm2413822d1_ex99-1.htm EX-99.1 439613
4 EXHIBIT 99.2 tm2413822d1_ex99-2.htm EX-99.2 148483
  Complete submission text file 0001104659-24-058866.txt   866724

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20240313.xsd EX-101.SCH 3027
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20240313_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20240313_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT tm2413822d1_8ka_htm.xml XML 4813
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
First Wave BioPharma, Inc. (Filer) CIK: 0001604191 (see all company filings)

IRS No.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37853 | Film No.: 24927526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)